Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The prevalence of type 2 diabetes has consistently increased and type 2 diabetes can cause many types of vascular complications. Diabetes develops due to glucose intolerance. Early detection and intervention in the stage of glucose intolerance makes it afford to prevent overt diabetes and its complications. This study was designed to make a cohort of korean patients with glucose intolerance to construct a long term database about clinical characteristics of these patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Diabetes and Impaired glucose Tolerance (G-CREDIT) | Patients with either type 2 diabetes or impaired glucose tolerance who are older than 20 years old and have attended Gangnam Severance hospital for regular follow up. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Life style assessment - Past medical history - Smoking, alcohol history - Sleep, exercise, daily activity check - Diet - Reproductive status (Women only) - Socioeconomic status | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| Past medical history | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| Smoking, alcohol history | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| Sleep, exercise, daily activity check | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| Diet | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| Reproductive status (Women only) | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
1. Patients with gestational diabetes, any active stage of cancer and severe disability
Not provided
Not provided
Patients with either type 2 diabetes or impaired glucose toloerance who are older than 20 years old and have attended Gangnam Severance hospital for regular follow up.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chul Woo Ahn, MD | Contact | 82-02-2019-3339 | acw@yuhs.ac |
Not provided
Not provided
This study has a plan to share data
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Whole blood sample in EDTA containing tube would be refrigerated and used in developing a new biomarker
| Socioeconomic status |
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications |
| an expected average of 12 weeks |
| Anthropometric measurements : Height, weight, waist circumference, pulse rate, blood pressure | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| SMA, TG, HDL, LDLM apoA, apoB | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| PC2hrs, HbA1C, Insulin, C-peptide (AC, PC2hr), hs-CRP | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| Urine protein, albumin, creatinine | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| EKG, Neurometer, Chest PA, Abdominal sonography | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| Fundus photography, fat computed tomography | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |
| HOMA-IR, HOMA-β | Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications | an expected average of 12 weeks |